Contract Services Contract Manufacturing

Samsung Biologics continues to leverage remote audits and regulatory inspections

Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments Recently hosted EMA for 6 PAIs simultaneously using ...

 June 24, 2021 | News

Vibalogics to expand cGMP manufacturing capacity for viral vectors

The investment by the CDMO, which specializes in the production of oncolytic viruses, viral vector vaccines and viral vector gene therapy products includes...

 June 17, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

  The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

 June 16, 2021 | News

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

 June 10, 2021 | News

iResearch Atlanta welcomes new investigators and expands its operations

iResearch Atlanta welcomes new investigators and expands its operations to serve more patients in phase I-IV clinical trials, the ability to cont...

 June 10, 2021 | News

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization, signed a strategic partnership with KAHR...

 June 03, 2021 | News

Moderna, Thermo Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered i...

 June 02, 2021 | News

Samsung Biologics to add mRNA vaccine DS production capability

Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022 The addition...

 June 01, 2021 | News

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership

Per the agreement, WuXi Biologics, as the exclusive CDMO partner will provide biologics development and cGMP manufacturing services for OncoC4’s prod...

 May 27, 2021 | News

Vetter Once Again Wins Axia Best Managed Companies Award

§  Internationally renowned seal of quality for exemplary corporate management §  Positive assessment of strategy, innovatio...

 May 26, 2021 | News

Moderna and South Korea Explore Collaboration on mRNA Vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Unde...

 May 24, 2021 | News

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leadin...

 May 24, 2021 | News

WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services

  Per the terms of the joint venture agreement, WuXi Biologics and WuXi STA will make capital contributions of USD120 million and USD8...

 May 14, 2021 | News

German CDMO Richter-Helm Triples to Accommodate Global Market Demand

“The market for pharmaceutical biotechnology has been continuously growing and further growth is expected. In order to accommodate demand for high va...

 May 09, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in